Procalcitonin: once is not enough.
The critical role of serial testing.

Webinar presenters Matthew Bell, Mike Broyles, PharmD, and Eric Gluck, MD, discuss current laboratory/clinical practice, how to use procalcitonin in sepsis and LRTI to determine when to start and stop antibiotic therapy, the importance of procalcitonin assay precision and sensitivity to support clinical decisions, and the impact of procalcitonin testing on antibiotic stewardship. This on-demand webinar originally broadcast on August 21, 2018.

Read More »

The aftermath of an overwhelming flu season,
a discussion on lessons learned

Webinar presenters Margie A. Morgan, PhD, D(ABMM), and Gregory J. Berry, PhD, D(ABMM), discuss the impacts of this past year’s flu season. This webinar will empower you to anticipate the impact of another significant flu season, assess your health care system testing needs; and choose the appropriate tests/algorithm for your lab. This on-demand webinar originally broadcast on August 15, 2018.

Read More »

Developing perspectives on BRCA testing: new horizons for breast cancer

Webinar presenters Tabetha Sundin, PhD, HCLD(ABB), MB(ASCP)CM and Leigha Senter-Jamieson, MS, discuss the rationale for BRCA mutation testing in breast cancer, key highlights of the BRCA testing and interpretation process, and reconsidering multi-disciplinary team roles and responsibilities to streamline the testing experience. This on-demand webinar was originally broadcast on March 29, 2018.

Read More »

Fecal matters: Molecular GI testing

Webinar presenters Daniel D. Rhoads, MD and Jose (Alex) Alexander, MD, D(ABMM), SM, MB(ASCP) discuss molecular GI testing, the application of new guidelines, the impact of molecular GI testing, and tips for implementation and justification. This on-demand webinar was originally broadcast on April 25, 2018.

Read More »

On demand webinar—Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

This webinar will empower you to learn the how and why of NGS testing for NSCLC therapy selection, how to practice precision oncology based on fast-changing guidelines and to ensure even challenging samples get tested to achieve best outcomes for as many NSCLC patients as possible, and Cancer Genetics Inc. (CGI) testing model, case studies and lessons learned. Originally broadcast: March 28, 2018

Read More »